Most large technology stocks clos lower
Most large technology Apple clos down 4.04%. Canalys data show that in the fourth quarter of 2024, Apple’s mobile phone […]
B2B lead
B2B lead
B2B lead
The number of initial jobless claims
The number of initial In the Unit States for the week ending January 11 was 217,000, the highest since the
B2B lead
ForwardLooking Statements
ForwardLooking For more information, please visit the company’s website: .innoventbio or the company’s LinkIn account: .linkincompanyinnoventbiologics . Statement: 1. Innovent
B2B lead
Click the following link to view the presentation PPT
Click the following Investor.innoventbiocninvestorswebcastsandpresentations About Innovent Biologics “Start with Integrity, Succe with Action” Developing c level executive list highquality biopharmaceuticals
B2B lead
IBI343 (CLDN18.2 ADC: Enrollment has been initiat for the Phase
IBI343 (CLDN18.2 ADC III multiregional clinical study (MRCT for gastric cancer in China and Japan. The Phase I clinical MRCT
B2B lead
Global business opens up future opportunities
Global business opens Focus on innovative technology platforms and key disease areas to build core competitiveness Innovent Biologics’ innovative R&D
B2B lead
In the 13 years since its establishment
In the 13 years Innovent Biologics has rapidly grown into a leading biopharmaceutical company in China. Under the guidance of
B2B lead
Alipay responds to major bug incident
Alipay responds Alipay issu a statement early this morning saying: Due to a mistake on our part yesterday afternoon, a
B2B lead
F’s Waller: Multiple rate cuts possible in 2025
F’s Waller: Multiple According to CNBC, F’s Waller said that this week’s CPI data was very good. If there is
B2B lead
Biden may leave enforcement of TikTok ban to Trump
Biden may leave The Company, its directors, employees and agents disclaim any (a obligation to correct or update the forwardlooking
B2B lead
Innovent Biologics ForwardLooking Statement
Innovent Biologics Aosaikang Pharmaceutical makes efforts in both independent research and development and introduction and cooperation, focusing on the research
B2B lead
About Aosaikang Pharmaceutical
About Aosaikang The company has 14 products approv for marketing, including sintilimab injection (Daboshu®, bevacizumab injection ( Dayoutong® , adalimumab
B2B lead
About EGFRmutant NSCLC
About EGFRmutant Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world [1